查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1847822

藥用明膠市場（按來源、類型、形式、應用和分銷管道）—2025-2032 年全球預測

Pharmaceutical Gelatin Market by Source, Type, Form, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年藥用明膠市場將成長至 21.4 億美元，複合年成長率為 6.63%。

主要市場統計數據
基準年2024年 12.8億美元
預計2025年 13.6億美元
預測年份：2032年 21.4億美元
複合年成長率（%） 6.63%

關於藥用明膠基礎知識、監管預期以及影響配方和採購決策的供應考慮因素的全面介紹

藥用明膠在製劑、封裝和包衣應用中發揮至關重要的作用，其材料完整性直接影響產品穩定性和患者療效。本執行摘要的引言部分闡述了明膠的功能特性（生物相容性、成膜性和可控溶出行為），並將明膠納入製劑開發生命週期。監管審查、供應鏈連續性和原料可追溯性是決定採購和製劑風險狀況的核心因素。

隨著產業轉向以患者為中心的劑型和永續採購，明膠供應商和原料藥商必須協調性能要求與道德和監管期望。新的品質框架強調從供應商到最終產品的記錄，要求膠囊製造商、API 配方師和分析實驗室之間更緊密的合作。因此，關於來源選擇、製程參數和供應商合格的策略決策如今已成為商業性開發計畫中的重要因素。

整體引言表明，明膠並非僅僅是一種惰性賦形劑，而是一種其來源、形態和加工過程會影響監管結果、生產效率和治療效果的材料。後續章節將深入探討轉型變革、關稅影響、市場區隔考量、區域動態、競爭定位、可操作建議、調查方法以及支持商業性決策的結論。

永續性、進階分析和不斷提高的品質期望如何重塑明膠採購、製造實踐和供應商夥伴關係關係

藥用明膠領域正在經歷一系列趨同變化，這些變化正在重塑籌資策略和產品開發路徑。對永續性和動物福利的日益重視，使得對原料來源和加工過程的審查日益嚴格，促使製造商擴展可追溯性機制並尋求替代採購。同時，分析化學和製程驗證的進步也提高了品管的標準，要求對批次間殘留溶劑、微生物極限和功能性能進行更嚴格的測試。

同時，數位化供應鏈技術和近乎即時的分析技術正在實現更嚴格的庫存控制，並提升上游物料流的可視性。這些功能減少了批次間差異，並支援準時制生產，同時又不犧牲合規性。此外，客戶對潔淨標示和符合道德標準的原料的偏好正在影響採購政策，並推動那些能夠展現負責任採購精神的供應商獲得溢價。

總的來說，這些轉變正在改變商業性關係。採購負責人越來越尋求建立​​在共用品質系統和透明度基礎上的長期夥伴關係。因此，積極投資於可追溯性、環境管理和嚴格測試通訊協定的公司，能夠更好地吸引那些為現代製藥應用尋求可靠明膠供應的配方師。

評估關稅對明膠採購、庫存策略、配方時間表和影響供應商多樣化的彈性措施的累積影響

近期徵收的關稅和不斷變化的貿易政策，為全球供應鏈中的明膠買家和製造商的採購計劃和成本結構帶來了新的動態。關稅不僅影響到岸成本，還會影響供應商選擇、庫存策略以及原料來源的地理多元化。因此，採購團隊正在重新評估垂直整合方案和在地採購，以降低關稅波動帶來的風險。

關稅帶來的成本壓力促使企業推行更嚴格的供應商審核，並協商簽訂長期合約以鎖定供應條款和穩定性。同時，企業正在多個採購區域採取對沖策略，以確保即使在貿易措施擾亂傳統航運路線的情況下也能持續供應。這些調整也輔以營運調整，例如在策略性製造地增加安全庫存，以及加強商業規劃和物流團隊之間的合作。

重要的是，關稅的累積影響不僅限於單位成本，還會影響創新時間表和打入市場策略。總體而言，貿易措施鼓勵設計更具韌性的供應鏈，重點是靈活性、多來源採購和合約機制，以平衡成本控制與持續獲得高品質明膠。

綜合細分分析揭示了來源、類型、形式、應用和分銷選擇如何共同決定明膠的性能和供應風險狀況

透過多種分析視角審視市場，深入了解原料選擇、加工方案和通路動態，以獲得市場區隔洞察。在區分牛、魚和豬來源時，每種來源都體現出獨特的感官、文化和監管考量，這些考量會影響配方決策和市場接受度。來源地選擇通常受終端市場敏感性、區域飲食限制以及劑型所需的特定功能屬性的影響。

按類型（A 型與 B 型）評估材料，可以揭示凝膠強度和等電性質的差異，這些差異會影響水合作用、凝膠化行為以及與活性成分的相互作用。這些基於類型的特性指南工程師最佳化膠囊硬度、溶出曲線以及與包封活性成分的相容性。粉末和片狀外形規格之間的差異會影響生產能力、操作和溶出動力學。粉末形態更適合靈活劑量和快速混合，而片狀形態則支援連續包封生產線，並可能影響薄膜的均勻性。

基於應用的細分，包括硬膠囊、丸劑、軟膠囊和片劑包衣，體現了不同劑型的功能需求如何變化，從而需要客製化明膠等級、塑化劑系統和加工條件。分銷管道——直銷、經銷商和線上——具有不同的風險敞口和服務期望，直銷交易更傾向於客製化化的技術支持，而線上管道則更傾向於採購速度和價格透明度。整合這些細分維度，使相關人員能夠根據配方目標和市場准入要求，調整產品規格和供應策略。

區域動態比較，說明美洲、歐洲、中東和非洲以及亞太地區的差異如何推動採購、合規和打入市場策略

區域動態對採購選擇、法律規範和終端市場需求模式有顯著的影響。在美洲，採購策略通常受以下因素影響：成熟的製造群、可追溯性的監管要求，以及支持各種膠囊和包衣明膠等級的成熟供應基地。該地區的生產和分銷網路優先考慮及時的物流和合規性，這體現在供應商資格認證通訊協定和庫存配置中。

歐洲、中東和非洲地區管理體制複雜，文化飲食要求多樣，需求也各異。該地區的製造商會權衡清真、猶太潔食和其他認證需求與環境因素，從而影響其採購和供應商審核實踐。該地區的監管審查強調文件記錄和衛生標準的遵守，從而凸顯了供應商透明度和原產地控制的重要性。

亞太地區依然充滿活力，製藥產能不斷擴大，原料供應多樣化，品質標準也不斷改進。契約製造和學名藥生產的快速成長推動了對可靠明膠供應的需求，而本地籌資策略則力求在成本競爭力與國際競爭之間取得平衡。在整個亞太地區，跨境物流、認證要求和文化偏好持續影響明膠的採購和部署地點和方式。

競爭概況突顯了供應商在可追溯性、分析能力、合作品質協議和增值技術服務方面的差異化

明膠產業的競爭考察不僅在於價格，還在於供應商在可追溯性、品質保證和技術服務方面的能力。領先的供應商透過投資上游可追溯性系統、先進的分析實驗室以及為膠囊製造商和包衣配方製造商提供客製化產品開發支援來脫穎而出。這些能力使供應商能夠與客戶合作，制定符合嚴格溶離度和穩定性要求的規格，同時滿足其特定的監管文件要求。

夥伴關係模式已發展到包括聯合品質協議、聯合風險評估和多年期供應承諾，為下游和上游製造商提供安全保障。擁有多元化原料籌資策略和多模態物流選擇的公司在面臨供應中斷時更具韌性。此外，提供透明文件（例如CoC證書和第三方審核報告）的公司會受到注重品質的買家的優先考慮。

從商業化角度來看，提供配方諮詢服務、快速穩定性測試和客製化包裝方案的供應商具有更高的策略價值。這些服務可加快新劑型的上市速度，並支援快速擴大規模，從而提高客戶維繫，並在法規合規性和產品性能至關重要的市場中實現高階定位。

供應商和製造商可採取的策略重點包括增強可追溯性、多樣化採購、加強分析保證和擴大增值技術服務

產業領導者應優先考慮加強供應安全、產品性能和監管合規性的策略性舉措。投資建置從原料產地到最終產品的全面追溯系統，將降低合規風險並強化商業性關係。同樣重要的是採用支援功能性能測試的先進分析平台，這將使不同生產批次之間的膠囊和包衣性能更加一致。

在營運方面，建立多採購策略和地理分佈的庫存可以減少貿易政策變化和物流中斷帶來的風險。領導者應透過基於績效的合約和共同應急計劃，正式確立與供應商的夥伴關係，以促進供應安全和責任共擔。在商業方面，記錄明膠產品的永續性屬性和資質，可以滿足買家的偏好，並使其能夠進入存在飲食和道德限制的市場。

最後，企業應透過整合技術支援、穩定性測試和快速回應故障排除來擴展其價值提案，從而加快客戶的產品開發週期。透過將技術服務與策略採購和強大的品質系統相結合，行業領導者可以強化其市場定位，並使其客戶能夠為患者提供更安全、更可靠的劑型。

透明的混合方法研究設計結合了相關人員訪談、技術文獻綜合、交易流程分析和專家檢驗，確保可靠的策略見解

本執行摘要背後的調查方法結合了原始資料和二手資料，以確保獲得可靠且可操作的見解。原始資料包括與來自製造和供應商組織的採購主管、配方科學家以及品質保證專業人員的結構化訪談。這些對話為採購決策標準、品質期望以及應對不斷變化的貿易措施和法規的營運調整提供了背景資訊。

二次分析整合了同行評審文獻、監管指導文件和公開的技術規範，以檢驗關於明膠類型、形態和特定應用要求的功能性假設。貿易流量和物流數據為跨境採購和庫存策略提供見解。對這些資訊來源進行三角檢驗，確保結論既能反映從業人員的經驗，又能反映已記錄的標準。

該方法強調假設的透明度、分析方法的可重複性，以及使用多種支持數據來支持每個主題洞察。品管包括訪談結果的交叉檢驗、技術規範的專家評審，以及基於相關人員的結論的迭代改進。

綜合結論強調，需要將明膠選擇視為由來源、分析和供應彈性驅動的跨職能策略決策。

結論部分概括了執行摘要的核心主題：明膠材料的特性和來源日益決定配方的成功、法規遵循和市場接受度。相關人員必須應對永續性預期、日益嚴格的分析標準以及貿易相關的成本波動等日益加劇的壓力。因此，韌性的建構需要透過多元化的採購、強大的可追溯性以及供應商和製造商之間的增值技術合作來實現。

具有前瞻性思維的組織將明膠的選擇視為一項跨職能決策，涉及採購、研發、品質和法規遵循，而非商品化的採購選擇。透過將技術支援、永續性認證和正式的供應商風險管理整合到其採購框架中，製造商可以更確定產品性能和法規遵循。總而言之，獲得競爭優勢的途徑在於將材料科學的嚴謹性與供應鏈彈性以及以客戶為中心的服務相結合，從而加快開發進度並支持合規的商業化。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 潔淨標示藥物配方中擴大採用植物來源的明膠替代品
  • 明膠輔料生產中殘留溶劑含量的嚴格規定
  • 藥用明膠來源永續海洋膠原蛋白的成長將減少對環境的影響
  • 使用酵素交聯技術增強先進藥物傳輸系統中明膠的穩定性
  • 利用明膠基生物墨水實施微膠囊化和 3D 列印技術開發新型劑型

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 藥用明膠市場（依來源）

  • 牛
  • 魚
  • 豬

9. 藥用明膠市場類型

  • A型
  • B型

10. 藥用明膠市場（依形態）

  • 粉末
  • 床單

第11章藥用明膠市場應用

  • 硬膠囊
  • 顆粒
  • 軟膠囊
  • 藥片包衣

12. 藥用明膠市場（依分銷管道）

  • 直接地
  • 批發商
  • 線上

13. 藥用明膠市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章藥用明膠市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 藥用明膠市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Darling Ingredients Inc.
    • Gelita AG
    • Nitta Gelatin Inc.
    • PB Leiner NV
    • Nippi Inc.
    • Weishardt International SAS
    • Tessenderlo Group NV
    • Danish Crown Protein A/S
    • Italgelatin SpA
    • MV Protein Inc.
Product Code: MRR-4F4C36263656

The Pharmaceutical Gelatin Market is projected to grow by USD 2.14 billion at a CAGR of 6.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.28 billion
Estimated Year [2025] USD 1.36 billion
Forecast Year [2032] USD 2.14 billion
CAGR (%) 6.63%

Comprehensive contextual orientation to pharmaceutical gelatin fundamentals, regulatory expectations, and supply considerations that drive formulation and sourcing decisions

Pharmaceutical gelatin occupies a pivotal role across formulation, encapsulation, and coating applications, where material integrity directly influences product stability and patient outcomes. The introduction to this executive summary establishes the material's functional attributes-biocompatibility, film-forming capability, and controlled dissolution behavior-while situating gelatin within the broader lifecycle of dosage-form development. Regulatory scrutiny, supply chain continuity, and raw material traceability are central themes that determine procurement and formulation risk profiles.

As the industry shifts toward patient-centric dosage forms and sustainable sourcing, gelatin suppliers and pharmaceutical manufacturers must reconcile performance demands with ethical and regulatory expectations. Emerging quality frameworks emphasize documentation from source to finished product, requiring closer collaboration between capsule makers, active pharmaceutical ingredient formulators, and analytical labs. Consequently, strategic decisions about source selection, processing parameters, and supplier qualification now factor prominently into commercial development plans.

Taken together, the introduction frames gelatin not merely as an inert excipient but as a material whose provenance, form, and processing influence regulatory outcomes, manufacturing efficiency, and therapeutic performance. The subsequent sections delve into transformative shifts, tariff impacts, segmentation insights, regional dynamics, competitive positioning, actionable recommendations, methodology, and concluding reflections that support commercially defensible decision-making.

How sustainability, advanced analytics, and heightened quality expectations are collectively reshaping gelatin sourcing, manufacturing practices, and supplier partnerships

The landscape for pharmaceutical gelatin is experiencing convergent changes that are reshaping sourcing strategies and product development pathways. Rising emphasis on sustainability and animal welfare has intensified scrutiny on raw material origin and processing, prompting manufacturers to expand traceability mechanisms and seek alternative sources. Meanwhile, advances in analytical chemistry and process validation have raised the bar for quality control, requiring more granular testing for residual solvents, microbial limits, and functional performance across lots.

Concurrently, digital supply chain technologies and near-real-time analytics are enabling tighter inventory control and better visibility into upstream raw material flows. These capabilities reduce batch-to-batch variability and support just-in-time manufacturing without sacrificing compliance. Additionally, customer preferences toward clean-label and ethically sourced ingredients influence procurement policies, driving premium positioning for suppliers who can certify responsible sourcing.

Taken together, these shifts are transforming commercial relationships: purchasers increasingly demand long-term partnerships founded on shared quality systems and transparency. As a result, companies that proactively invest in traceability, environmental stewardship, and robust testing protocols are better positioned to capture formulators seeking reliable gelatin supplies for modern pharmaceutical applications.

Assessment of cumulative tariff effects on gelatin procurement, inventory strategies, and resilience measures that influence formulation timelines and supplier diversification

The imposition of tariffs and trade policy shifts in recent years has introduced new dynamics to procurement planning and cost structures for gelatin buyers and manufacturers operating in global supply chains. Tariff layers affect not only landed cost but also supplier selection, inventory strategy, and the geographic diversification of raw material sources. In response, procurement teams have re-evaluated vertical integration options and local sourcing to mitigate exposure to customs volatility.

Tariff-driven cost pressures have encouraged companies to pursue more rigorous supplier audits and to negotiate longer-term contracts that lock in supply terms and stability. At the same time, organizations have adopted hedging strategies across multiple sourcing regions to preserve continuity of supply when trade measures disrupt conventional shipping lanes. These adjustments are complemented by operational adaptations such as increased safety stock at strategically located manufacturing sites and closer alignment between commercial planning and logistics teams.

Importantly, the cumulative impact of tariffs extends beyond per-unit cost; it influences innovation timelines and market entry strategies. Firms evaluating new capsule formats or coating technologies now incorporate tariff scenarios into feasibility assessments and go-to-market projections. Overall, trade measures have catalyzed more resilient supply chain design, emphasizing flexibility, multi-sourcing, and contractual mechanisms that balance cost management with uninterrupted access to quality gelatin.

Integrated segmentation analysis revealing how source, type, form, application, and distribution choices collectively determine gelatin performance and supply risk profiles

Segmentation insight emerges when the market is examined through multiple analytical lenses that highlight material selection, processing choices, and channel dynamics. When considering source differentiation across bovine, fish, and porcine origins, each option presents distinctive sensory, cultural, and regulatory considerations that shape formulation decisions and market acceptability. Source selection is often driven by end-market sensitivities, regional dietary constraints, and the specific functional attributes required by the dosage form.

Evaluating the material by type-Type A versus Type B-reveals differences in gel strength and isoelectric properties that influence hydration, gelling behavior, and interaction with active ingredients. These type-driven characteristics guide technologists when optimizing capsule hardness, dissolution profiles, and compatibility with encapsulated actives. Form factor distinctions between powder and sheet formats affect manufacturing throughput, handling, and dissolution kinetics; powder forms lend themselves to flexible dosing and rapid blending, whereas sheets support continuous encapsulation lines and can influence film uniformity.

Application-based segmentation-encompassing hard capsule, pellets, soft capsule, and tablet coating-demonstrates how functional requirements vary across dosage forms, requiring tailored gelatin grades, plasticizer systems, and processing conditions. Distribution channels-direct procurement, distributor-mediated supply, and online sourcing-create different risk exposures and service expectations, with direct relationships favoring customized technical support and online channels offering procurement speed and price transparency. By integrating these segmentation dimensions, stakeholders can align product specifications and supply strategies with formulation goals and market access requirements.

Comparative regional dynamics explaining how Americas, Europe, Middle East & Africa, and Asia-Pacific variations drive sourcing, compliance, and market access strategies

Regional dynamics exert a pronounced influence on sourcing options, regulatory frameworks, and end-market demand patterns. In the Americas, purchasing strategies are often shaped by established manufacturing clusters, regulatory expectations for traceability, and a mature supply base that supports a range of gelatin grades for capsules and coatings. Production and distribution networks in this region prioritize timely logistics and regulatory compliance, which informs supplier qualification protocols and inventory positioning.

Europe, Middle East & Africa present a complex mosaic of regulatory regimes, cultural dietary requirements, and demand heterogeneity. Manufacturers in this region weigh halal, kosher, and other certification needs alongside environmental considerations, which affects source selection and supplier auditing practices. The region's regulatory scrutiny emphasizes documentation and adherence to sanitary standards, thereby elevating the importance of supplier transparency and provenance controls.

Asia-Pacific remains a dynamic region with expanding pharmaceutical manufacturing capacity, diverse raw material endowments, and evolving quality norms. Rapid growth in contract manufacturing and generic production has increased demand for reliable gelatin supplies, while local sourcing strategies seek to balance cost competitiveness with international compliance expectations. Across regions, cross-border logistics, certification requirements, and cultural preferences continue to shape where and how gelatin is sourced and deployed.

Competitive profile emphasizing supplier differentiation through traceability, analytical capabilities, collaborative quality agreements, and value-added technical services

Competitive insight in the gelatin arena centers on supplier capabilities in traceability, quality assurance, and technical service rather than solely on price. Leading suppliers differentiate through investments in upstream traceability systems, advanced analytical laboratories, and customized product development support for capsule manufacturers and coating formulators. These capabilities enable suppliers to co-develop specifications that meet stringent dissolution and stability requirements while addressing client-specific regulatory dossiers.

Partnership models have evolved to include collaborative quality agreements, joint risk assessments, and multi-year supply commitments that provide security for both downstream manufacturers and upstream producers. Companies that maintain diversified raw material procurement strategies and multi-modal logistics options are more resilient in the face of disruption. Additionally, organizations that provide transparent documentation, such as chain-of-custody certificates and third-party audit reports, gain preferential consideration among quality-driven buyers.

From a commercialization perspective, suppliers that offer formulation advisory services, rapid-response stability testing, and tailored packaging options command higher strategic value. These services reduce time-to-market for new dosage forms and support rapid scale-up, thereby strengthening customer retention and enabling premium positioning in a market where regulatory compliance and product performance are paramount.

Actionable strategic priorities for suppliers and manufacturers to strengthen traceability, diversify sourcing, enhance analytical assurance, and expand value-added technical services

Industry leaders should prioritize strategic initiatives that enhance supply assurance, product performance, and regulatory alignment. Investing in comprehensive traceability systems from raw material origin through finished product will reduce compliance risk and strengthen commercial relationships. Equally important is the adoption of advanced analytical platforms that support functional performance testing, enabling more consistent capsule and coating behavior across production batches.

Operationally, establishing multi-sourcing strategies and geographically diversified inventories can reduce exposure to trade policy shifts and logistics disruptions. Leaders should formalize supplier partnerships through performance-based contracts and mutual contingency planning, which fosters supply stability and shared accountability. On the commercial front, positioning gelatin offerings with documented sustainability attributes and certification credentials addresses buyer preferences and opens access to markets with dietary or ethical constraints.

Finally, companies should expand value propositions by bundling technical support, stability testing, and rapid-response troubleshooting to accelerate customer product development cycles. By aligning technical services with strategic sourcing and robust quality systems, industry leaders will strengthen market positioning and enable customers to deliver safer, more reliable dosage forms to patients.

Transparent mixed-method research design combining stakeholder interviews, technical literature synthesis, trade flow analysis, and expert validation to ensure reliable strategic insights

The research methodology underpinning this executive summary blends primary engagement and secondary validation to ensure robust, actionable insights. Primary inputs include structured interviews with procurement leaders, formulation scientists, and quality assurance professionals across manufacturing and supplier organizations. These dialogues provide context on sourcing decision criteria, quality expectations, and operational adaptations to trade measures and regulatory changes.

Secondary analysis synthesizes peer-reviewed literature, regulatory guidance documents, and publicly available technical specifications to validate functional assumptions about gelatin types, forms, and application-specific requirements. Trade flow and logistics data inform considerations about cross-border sourcing and inventory strategies, while case studies illustrate practical responses to supply disruptions and certification demands. Triangulation across these sources ensures that conclusions reflect both practitioner experience and documented standards.

Throughout the methodology, emphasis is placed on transparency of assumptions, reproducibility of analytical approaches, and the use of multiple corroborating data points to support each thematic insight. Quality controls include cross-validation of interview findings, review of technical specifications by subject-matter experts, and iterative refinement of conclusions to reflect stakeholder feedback.

Consolidated conclusion highlighting the need to treat gelatin selection as a cross-functional strategic decision driven by provenance, analytics, and supply resilience

The conclusion synthesizes the executive summary's central themes: gelatin's material attributes and provenance are increasingly determinative of formulation success, regulatory compliance, and market acceptance. Stakeholders must navigate converging pressures from sustainability expectations, heightened analytical standards, and trade-related cost fluctuations, which collectively shape procurement and innovation choices. Resilience is therefore built through diversified sourcing, robust traceability, and value-added technical collaboration between suppliers and manufacturers.

Forward-looking organizations will treat gelatin selection as a cross-functional decision involving procurement, R&D, quality, and regulatory affairs rather than a commoditized purchasing choice. By integrating technical support, sustainability credentials, and formalized supplier risk management into procurement frameworks, manufacturers can better assure product performance and regulatory readiness. In sum, the path to competitive advantage lies in aligning material science rigor with supply chain resilience and customer-centric service offerings that accelerate development timelines and support compliant commercialization.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of plant-based gelatin substitutes for clean label pharmaceutical formulations
  • 5.2. Increasing regulatory scrutiny on residual solvent levels in gelatin excipient production
  • 5.3. Growth of pharmaceutical gelatin sourcing from sustainable marine collagen to reduce environmental impact
  • 5.4. Use of enzymatic crosslinking techniques to enhance gelatin stability in advanced drug delivery systems
  • 5.5. Implementation of microencapsulation and 3D printing technologies using gelatin-based bio-inks for novel dosage forms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Gelatin Market, by Source

  • 8.1. Bovine
  • 8.2. Fish
  • 8.3. Porcine

9. Pharmaceutical Gelatin Market, by Type

  • 9.1. Type A
  • 9.2. Type B

10. Pharmaceutical Gelatin Market, by Form

  • 10.1. Powder
  • 10.2. Sheet

11. Pharmaceutical Gelatin Market, by Application

  • 11.1. Hard Capsule
  • 11.2. Pellets
  • 11.3. Soft Capsule
  • 11.4. Tablet Coating

12. Pharmaceutical Gelatin Market, by Distribution Channel

  • 12.1. Direct
  • 12.2. Distributor
  • 12.3. Online

13. Pharmaceutical Gelatin Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Gelatin Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Gelatin Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Darling Ingredients Inc.
    • 16.3.2. Gelita AG
    • 16.3.3. Nitta Gelatin Inc.
    • 16.3.4. PB Leiner NV
    • 16.3.5. Nippi Inc.
    • 16.3.6. Weishardt International SAS
    • 16.3.7. Tessenderlo Group NV
    • 16.3.8. Danish Crown Protein A/S
    • 16.3.9. Italgelatin SpA
    • 16.3.10. MV Protein Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 203. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 214. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 215. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 218. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 219. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 238. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 239. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 250. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 251. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 254. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 255. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 262. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 263. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 266. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 267. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 295. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 298. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 305. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 308. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 323. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 324. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 325. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 328. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 329. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 332. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 333. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 334. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 335. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 338. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 339. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 340. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 341. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 342. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 343. RUSSIA PHARMACEUTICAL GELA